免疫檢測市場規模、佔有率和成長分析：按產品類型、技術、生物標記類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024年全球免疫檢測市場價值為32億美元，預計2025年將成長至34.2億美元，2033年將成長至58.8億美元。預測期（2026-2033年）的複合年成長率預計為7.0%。

神經免疫免疫檢測市場專注於測量對中樞神經系統疾病診斷至關重要的免疫學和神經學標記的檢測方法。隨著神經退化性疾病疾病和神經發炎性疾病的日益普遍，對早期和微創診斷工具的需求也日益成長。從單分析物ELISA到包括超靈敏數位檢測在內的先進多重檢測平台的演變，顯著提高了檢測低濃度分析物的能力。這項進步凸顯了迫切的臨床需求，並推動了診斷公司和生物製藥合作夥伴的投資。技術靈敏度是關鍵的成長要素，它能夠提高檢測性能並擴大應用範圍。人工智慧尤其在推動市場成長和融入常規臨床實踐方面發揮著至關重要的作用，它能夠提高診斷準確性、規範品質檢查並實現更快、更可靠的臨床決策。

推動全球神經免疫免疫檢測市場發展的因素

全球神經免疫學檢測市場的發展主要得益於檢測靈敏度、特異性和多重檢測能力的顯著提升。這些改進增強了對各種檢體類型和疾病狀態下神經免疫生物標記的檢測能力，從而能夠更早、更準確地識別神經系統免疫反應。此外，製造商在試劑化學和檢測平台方面也不斷創新，提高了臨床應用的可靠性，並拓展了檢測在研究和診斷領域的應用範圍。這種技術進步降低了使用門檻，並透過開發專門針對神經發炎和神經退化性疾病研究的新型檢測方法和工作流程，推動了市場成長，最終促進了實驗室和臨床醫生對這些檢測方法的廣泛應用。

全球神經免疫學檢測市場的限制因素

全球神經免疫學檢測市場面臨嚴峻挑戰，主要原因是檢測方法的開發、臨床檢驗以及符合監管標準都需要大量投資。這些資金和時間上的障礙對小規模實驗室和新興製造商的影響尤其顯著，它們往往難以應對漫長的開發流程和合規要求。因此，市場競爭減弱，新產品上市延遲，市場上可供選擇的免疫檢測方法種類有限。儘管醫療機構對神經免疫學診斷的興趣和需求日益成長，但這種資金負擔阻礙了產品系列的快速擴張，並延緩了這些診斷工具在臨床實踐中的應用。

全球免疫檢測分析市場趨勢

全球神經免疫學檢測市場的一個顯著趨勢是其向照護現場檢測（POC​​T）領域的擴展。這些先進診斷工具的應用正從中心檢查室轉向診所和社區醫療機構。這一轉變的主要驅動力是人們對及時、可操作的生物標記資訊的需求日益成長，這對於改善患者照護和加快治療決策至關重要。簡化平台和攜帶式設備的開發使臨床醫生能夠在患者附近進行檢測，並將這些評估有效地整合到現有的臨床工作流程和電子健康記錄中。診斷服務的可近性提高促進了跨學科合作，並推動了專為門診環境設計的便捷檢測方法的創新。因此，神經免疫學檢測正逐漸成為現代醫療保健服務的核心要素。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球免疫檢測市場規模：依產品類型及複合年成長率分類（2026-2033 年）

• 試劑和試劑盒
  • 酵素免疫分析法試劑
  • 蛋白質印跡試劑盒
  • 多重檢測試劑盒
• 分析器
  • 自動免疫檢測裝置
  • 照護現場免疫檢測裝置
  • 高通量免疫檢測分析儀

全球免疫檢測市場規模：依技術及複合年成長率分類（2026-2033 年）

• 免疫測量（RIA）
• 聚合酵素鏈鎖反應（PCR）
• 酵素免疫分析法（ELISA）
• 西方墨點法
• 快速檢測
• 酵素介導免疫測定法（ELISPOT）

全球免疫檢測市場規模：按生物標記類型和複合年成長率分類（2026-2033 年）

• BETA-澱粉樣蛋白（AB）
• Tau蛋白（磷酸化Tau）
• α-突觸核蛋白（α-syn）
• 神經絲輕鏈（NfL）
• 自體抗體
• 細胞激素
• 膠質纖維酸性蛋白（GFAP）
• 神經元特異性烯醇化酶（NSE）
• 泛素C端水解酵素L1（UCH-L1）
• 腦源性神經營養因子（BDNF）

全球免疫檢測市場規模：依應用及複合年成長率分類（2026-2033 年）

• 阿茲海默症
• 帕金森氏症（PD）
• 亨丁頓舞蹈症
• 肌萎縮側索硬化症（ALS）
• 脊髓性肌肉萎縮症（SMA）

全球免疫檢測市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 診所
• 學術機構
• 生物製藥公司
• 製藥公司
• 其他最終用戶

全球免疫檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories Inc.
• GenScript Biotech Corporation
• Abcam plc
• BioLegend Inc.
• Meso Scale Diagnostics LLC
• Sino Biological Inc.
• Quanterix Corporation
• Cusabio Technology LLC
• OriGene Technologies Inc.
• Elabscience Biotechnology Inc.
• RayBiotech Life Inc.
• Enzo Life Sciences Inc.
• Rockland Immunochemicals Inc.
• Assay Genie Ltd.
• Novus Biologicals LLC
• Creative Diagnostics
• MyBioSource Inc.
• Immuno-Biological Laboratories Co. Ltd.
• Boster Biological Technology
• Cloud-Clone Corp.
• FineTest Biotech Inc.
• Abbexa Ltd.

結論與建議

Global Neuro Immunoassay Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.42 Billion in 2025 to USD 5.88 Billion by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).

The neuro immunoassay market focuses on assays that measure immune and neuronal biomarkers crucial for diagnosing central nervous system disorders. The increasing prevalence of neurodegenerative and neuroinflammatory diseases has heightened the demand for early and minimally invasive diagnostic tools. The evolution from single-analyte ELISAs to advanced multiplex platforms, including ultra-sensitive digital assays, has significantly improved detection capabilities for low-abundance analytes. This progress underscores the urgent clinical need driving investments from diagnostics firms and biopharma partners. Technological sensitivity is a key growth factor, enhancing assay performance and expanding applications. Notably, artificial intelligence plays a pivotal role by improving diagnostic accuracy, standardizing quality checks, and enabling quicker, more reliable clinical decisions, thereby propelling market growth and integration into routine care pathways.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuro Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuro Immunoassay Market Segments Analysis

Global neuro immunoassay market is segmented by product type, technology, biomarker type, application, end-user and region. Based on product type, the market is segmented into Reagents And Kits and Analyzers. Based on technology, the market is segmented into Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests and Enzyme-Linked Immunospot Assay (ELISPOT). Based on biomarker type, the market is segmented into Amyloid-Beta (AB), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) and Brain-Derived Neurotrophic Factor (BDNF). Based on application, the market is segmented into Alzheimer's Disease, Parkinson's Disease (PD), Huntington's Disease, Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). Based on end-user, the market is segmented into Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies and Other End-Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market is driven by significant advancements in assay sensitivity, specificity, and multiplexing capabilities, which enhance the detection of neuroimmune biomarkers across various sample types and disease conditions. These improvements facilitate earlier and more precise identification of neurological immune responses. Additionally, manufacturers are innovating reagent chemistry and detection platforms, boosting clinical confidence and expanding applications in both research and diagnostics. This technological evolution lowers usage barriers, promoting market growth by enabling the development of new assay formats and workflows tailored for neuroinflammatory and neurodegenerative research, ultimately leading to increased adoption among laboratories and clinicians.

Restraints in the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market faces significant challenges due to the substantial investments needed for assay development, clinical validation, and adherence to regulatory standards. These financial and temporal barriers disproportionately impact smaller laboratories and emerging manufacturers, which often struggle to navigate lengthy development processes and certification requirements. As a result, competition is diminished, and the introduction of new products is delayed, limiting the availability of diverse neuro immunoassays in the market. This economic strain hinders rapid portfolio expansion and slows the integration of these diagnostic tools into clinical practices, despite a growing interest and demand for neuroimmune diagnostics among healthcare providers.

Market Trends of the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market is witnessing a significant trend towards point-of-care expansion, with the adoption of these advanced diagnostic tools moving from central laboratories to clinics and community settings. This shift is primarily driven by the growing demand for timely and actionable biomarker information, which is essential for improving patient care and facilitating early treatment decisions. The development of simplified platforms and portable instruments enables clinicians to conduct tests closer to patients, effectively integrating these assessments into existing clinical workflows and electronic health records. Enhanced access to diagnostic services promotes collaboration across specialties and fuels innovation in user-friendly assays designed specifically for outpatient environments, positioning neuro immunoassays as a pivotal component in modern healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Neuro Immunoassay Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Reagents And Kits
  • Enzyme Linked Immunosorbent Assay Reagents
  • Western Blotting Kits
  • Multiplex Assay Kits
• Analyzers
  • Automated Immunoassay Analysers
  • Point Of Care Immunoassay Analysers
  • High Throughput Immunoassay Analysers

Global Neuro Immunoassay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Radioimmunoassays (RIA)
• Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Western Blot
• Rapid Tests
• Enzyme-Linked Immunospot Assay (ELISPOT)

Global Neuro Immunoassay Market Size by Biomarker Type & CAGR (2026-2033)

• Market Overview
• Amyloid-Beta (AB)
• Tau Protein (p-Tau)
• Alpha-Synuclein (a-syn)
• Neurofilament Light Chain (NfL)
• Autoantibodies
• Cytokines
• Glial Fibrillary Acidic Protein (GFAP)
• Neuron-Specific Enolase (NSE)
• Ubiquitin C-Terminal Hydrolase L1 (UCH-L1)
• Brain-Derived Neurotrophic Factor (BDNF)

Global Neuro Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Alzheimer's Disease
• Parkinson's Disease (PD)
• Huntington's Disease
• Amyotrophic Lateral Sclerosis (ALS)
• Spinal Muscular Atrophy (SMA)

Global Neuro Immunoassay Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Academic Organizations
• Biopharmaceutical Companies
• Pharmaceutical Companies
• Other End-Users

Global Neuro Immunoassay Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Biomarker Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Technology, Biomarker Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Biomarker Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Biomarker Type, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Biomarker Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meso Scale Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanterix Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cusabio Technology LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elabscience Biotechnology Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Life Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Assay Genie Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyBioSource Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immuno-Biological Laboratories Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boster Biological Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cloud-Clone Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineTest Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbexa Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations